Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac608 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Carlos Mejia-Chew und 39 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Organ Transplantation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Swiss National Science Foundation, Washington University School of Medicine in St. Louis.
Abstract (Originalsprache)
Background
Risk factors for nontuberculous mycobacteria (NTM) infections after solid organ transplant (SOT) are not well characterized. Here we aimed to describe these factors.
Methods
Retrospective, multinational, 1:2 matched case-control study that included SOT recipients ≥12 years old diagnosed with NTM infection from 1 January 2008 to 31 December 2018. Controls were matched on transplanted organ, NTM treatment center, and post-transplant survival greater than or equal to the time to NTM diagnosis. Logistic regression on matched pairs was used to assess associations between risk factors and NTM infections.
Results
Analyses included 85 cases and 169 controls (59% male, 88% White, median age at time of SOT of 54 years [interquartile range {IQR} 40–62]). NTM infection occurred in kidney (42%), lung (35%), heart and liver (11% each), and pancreas transplant recipients (1%). Median time from transplant to infection was 21.6 months (IQR 5.3–55.2). Most underlying comorbidities were evenly distributed between groups; however, cases were older at the time of NTM diagnosis, more frequently on systemic corticosteroids and had a lower lymphocyte count (all P < .05). In the multivariable model, older age at transplant (adjusted odds ratio [aOR] 1.04; 95 confidence interval [CI], 1.01–1.07), hospital admission within 90 days (aOR, 3.14; 95% CI, 1.41–6.98), receipt of antifungals (aOR, 5.35; 95% CI, 1.7–16.91), and lymphocyte-specific antibodies (aOR, 7.73; 95% CI, 1.07–56.14), were associated with NTM infection.
Conclusions
Risk of NTM infection in SOT recipients was associated with older age at SOT, prior hospital admission, receipt of antifungals or lymphocyte-specific antibodies. NTM infection should be considered in SOT patients with these risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
- College of Pharmacy, The University of Michigan, Ann Arbor, Michigan, USA.
- Hospital Israelita Albert Einstein, São Paulo, Brazil.
- Division of Infectious Diseases, Department of Medicine, The University of British Columbia Faculty of Medicine, Vancouver, Canada.
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
- Department of Medicine, Division of Infectious Diseases & Immunology, UMass Chan Medical School, Worchester, Massachusetts, USA.
ORCID-Profile: Carlos Mejia-Chew
Förderung
- Swiss National Science Foundation
- Washington University School of Medicine in St. Louis
Zitieren
APA
Mejia-Chew, C., Carver, P. L., Rutjanawech, S., Camargo, L. F. A., Fernandes, R., Belga, S., Daniels, S. A., Müller, N. J., Burkhard, S., Theodoropoulos, N. M., Postma, D. F., van Duijn, P. J., Fariñas, M. C., González-Rico, C., Hand, J., Lowe, A., Bodro, M., Vanino, E., Cruz, A. F., …, & López-Medrano, F. (2023). Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac608
Vancouver
Mejia-Chew C, Carver PL, Rutjanawech S, Camargo LFA, Fernandes R, Belga S, et al. Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac608
BibTeX
@article{MejiaChew2023,
author = {Mejia-Chew, Carlos and Carver, Peggy L and Rutjanawech, Sasinuch and Camargo, Luis F Aranha and Fernandes, Ruan and Belga, Sara and Daniels, Shay-Anne and Müller, Nicolas J and Burkhard, Sara and Theodoropoulos, Nicole M and Postma, Douwe F and van Duijn, Pleun J and Fariñas, María Carmen and González-Rico, Claudia and Hand, Jonathan and Lowe, Adam and Bodro, Marta and Vanino, Elisa and Cruz, Ana Fernández and Ramos, Antonio and Makek, Mateja Jankovic and Mjahed, Ribal Bou and Manuel, Oriol and Kamar, Nassim and Calvo-Cano, Antonia and Carrasco, Laura Rueda and Muñoz, Patricia and Rodríguez, Sara and Pérez-Recio, Sandra and Sabé, Núria and Álvarez, Regino Rodríguez and Silva, José Tiago and Mularoni, Alessandra and Vidal, Elisa and Alonso-Titos, Juana and Del Rosal, Teresa and Classen, Annika Y and Goss, Charles W and Agarwal, Mansi and López-Medrano, Francisco},
title = {Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac608}
}
EUVIMED